MO-0556 Reduction of the CTV margin in glioblastoma leads to dosimetric benefit without compromising outcome.
Saved in:
| Title: | MO-0556 Reduction of the CTV margin in glioblastoma leads to dosimetric benefit without compromising outcome. |
|---|---|
| Authors: | Di Perri, D. (AUTHOR), Hartgerink, D. (AUTHOR), Terhaag, K. (AUTHOR), Houben, R. (AUTHOR), Compter, I. (AUTHOR), Eekers, D. (AUTHOR) |
| Source: | Radiotherapy & Oncology. 2023 Supplement 1, Vol. 182, pS435-S437. 3p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 166737428 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: MO-0556 Reduction of the CTV margin in glioblastoma leads to dosimetric benefit without compromising outcome. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Di+Perri%2C+D%2E%22">Di Perri, D.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hartgerink%2C+D%2E%22">Hartgerink, D.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Terhaag%2C+K%2E%22">Terhaag, K.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Houben%2C+R%2E%22">Houben, R.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Compter%2C+I%2E%22">Compter, I.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Eekers%2C+D%2E%22">Eekers, D.</searchLink> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Radiotherapy+%26+Oncology%22">Radiotherapy & Oncology</searchLink>. 2023 Supplement 1, Vol. 182, pS435-S437. 3p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=166737428 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S0167-8140(23)08412-8 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 3 StartPage: S435 Titles: – TitleFull: MO-0556 Reduction of the CTV margin in glioblastoma leads to dosimetric benefit without compromising outcome. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Di Perri, D. – PersonEntity: Name: NameFull: Hartgerink, D. – PersonEntity: Name: NameFull: Terhaag, K. – PersonEntity: Name: NameFull: Houben, R. – PersonEntity: Name: NameFull: Compter, I. – PersonEntity: Name: NameFull: Eekers, D. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 05 Text: 2023 Supplement 1 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 01678140 Numbering: – Type: volume Value: 182 Titles: – TitleFull: Radiotherapy & Oncology Type: main |
| ResultId | 1 |